← SynDRA
TANESPIMYCIN
SynDRA canonical compound SYN0004159 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | CHEK1 | HSP90AA1 |
| Mechanism of action | HSP inhibitor |
All known targets
Mechanisms of action (all sources)
- HSP90AA1 INHIBITOR
- Heat shock protein HSP90 inhibitor
- HSP90AB1 INHIBITOR
- HSP inhibitor
Cross-references
Synonyms
- Tanespimycine
- Tanespimicina
- 17aag
- 17-AAG
- BMS-722782
- CNF-1010
- CNF1010
- KOS-953
- NSC-330507
- CNF-101
- [(3S,5S,6R,7S,8E,10R,11S,12E,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate
- [(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate
- 17AAG, Tanespimycin, Geldanamycin, NSC330507, 17-(Allylamino)-17-demethoxygeldanamycin, CP 127374
- 17-(Allylamino)-17-demethoxygeldanamycin
- 17AAG
- NSC 330507
- 17-(Allylamino)geldanamycin
- KOS 953
- 17-Allylaminogeldanamycin
- CP-127374
- 17-Demethoxy-17-allylamino geldanamycin
- Tanespimycin [USAN]
- CHEBI:64153
- 17-AAG (Tanespimycin)
- 4GY0AVT3L4
- 17-demethoxy-17-(2-propenylamino)geldanamycin
- Geldanamycin, 17-demethoxy-17-(2-propenylamino)-
- Tanespimycin (USAN)
- NCGC00163424-01
- 17-N-allylamino-17-demethoxygeldanamycin
- [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
- NSC330507
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- Tanespimycin [USAN:INN]
- UNII-4GY0AVT3L4
- tanespimycina
- tanespimycine
- tanespimycinum
- CCRIS 9401
Look up TANESPIMYCIN in the interactive SynDRA portal →